Myotonic Dystrophy Pipeline 2026: Critical FDA Approvals and Promising Clinical Trials Reshape Treatment Sector
March 18, 2026 — The therapeutic space for Myotonic Dystrophy (DM), a complex and debilitating genetic disorder, is undergoing a...
March 18, 2026 — The therapeutic space for Myotonic Dystrophy (DM), a complex and debilitating genetic disorder, is undergoing a...